Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer

File(s)

Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer.pdf (114.8 KB)

Published version

Show more

Author(s)

Michalaki, V

Syrigos, K

Charles, P

Waxman, J

Type

Journal Article

Date Issued

2004-06-14

URI

http://hdl.handle.net/10044/1/52688

DOI

https://dx.doi.org/10.1038/sj.bjc.6601814

ISSN

0007-0920

Publisher

NATURE PUBLISHING GROUP

Start Page

2312

End Page

2316

Journal / Book Title

BRITISH JOURNAL OF CANCER

Volume

90

Issue

12

Copyright Statement

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222427100009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

cytokines

IL-6

TNF-alpha

prostate cancer

TUMOR-NECROSIS-FACTOR

ANDROGEN RECEPTOR

PROGNOSTIC-FACTOR

CELL-LINE

INTERLEUKIN-6

PROGRESSION

LNCAP

EXPRESSION

CARCINOMA

INHIBITION

Aged

Biomarkers, Tumor

Case-Control Studies

Disease Progression

Humans

Interleukin-6

Male

Middle Aged

Neoplasm Metastasis

Prognosis

Prospective Studies

Prostate-Specific Antigen

Prostatic Neoplasms

Survival Analysis

Tumor Necrosis Factor-alpha

Tumor Markers, Biological

1112 Oncology And Carcinogenesis

Oncology & Carcinogenesis

Publication Status

Published